Pharma is vulnerable. The sector, which bridges the healthcare–business divide and deals extensively with data and intellectual property (IP), is a tantalizing prospect for malicious actors. It is now one of the most targeted sectors, according to Deloitte, with over a fifth of companies suffering at least seven attacks.
Perhaps the greatest threat facing the pharma industry, however, lies inside the walls. That’s because insider threats are as much a public health issue as they are an economic one; they hamper a pharma company’s ability to remain competitive, and thus pose a risk to potential patients. IP may become inaccessible, which could affect drug production and lead to medicine running short.
Emerging Threat Simulation
This interactive webinar throws attendees into an emerging insider threat simulation taking place at a fictional pharmaceutical company. In this scenario, participants must use their decision-making skills to find the insider threat, manage the growing crisis, and prevent the loss of potentially billions of dollars.
Check out this webinar to:
- See the impact of the human element in crisis management and response
- Gain a greater understanding of how decisions in a threat scenario have a business-wide impact
- Discover how to strengthen your organization on both sides of “the boom”, so it’s as ready before the impact as it is after it
- And more
8 April 2021